<?xml version="1.0" encoding="UTF-8"?>
<results title="test_trace">
 <result pre="[4,5,6]. The vaccines based on classic strains failed to control" exact="infection" post="[2]. Furthermore, a vaccine-resistant PEDV strain emerged in the"/>
 <result pre="and coronaviruses in enzymatic or cell-based assays [35,36,37]. Notably, antiviral" exact="treatment" post="with GC376 leads to a full recovery in laboratory"/>
 <result pre="80%–90% confluence, the virus was added at a multiplicity of" exact="infection" post="(MOI) of 0.01 with a series of GC376 concentrations"/>
 <result pre="h respectively); however, GC376 showed similar inhibitory effects with different" exact="treatment" post="times for the two viruses, which indicates that GC376"/>
 <result pre="strains, YN144. Compared with the non-drug-treated cells, GC376 reduced virus" exact="infection" post="at 1.56 μM (Figure 3C). It almost completely inhibited"/>
 <result pre="larger volume. The EC50 of the two compounds fir YN144" exact="infection" post="was measured to evaluate optimization effects. Targets 1 and"/>
 <result pre="feline calicivirusesJ. Virol.2015894942495010.1128/JVI.03688-1425694593 18.KimY.LiuH.KankanamalageA.C.G.WeerasekaraS.HuaD.H.GroutasW.C.ChangK.O.PedersenN.C.Reversal of the progression of fatal coronavirus" exact="infection" post="in cats by a broad-spectrum coronavirus protease inhibitorPLoS Pathog.201612e100553110.1371/journal.ppat.100553127027316"/>
 <result pre="cell culture. (A) CV777 was added at a multiplicity of" exact="infection" post="(MOI) of 0.01 with a series of GC376 concentrations"/>
 <result pre="in the figure; (C,D) viability of YN144-infected Vero cells after" exact="treatment" post="with the two GC376 variants, Target 1 (L-M) and"/>
</results>
